M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
XOMA Royalty Corp to acquire Pulmokine
Announced Dec 2, 2024 · Closed Dec 2, 2024 · Private target
Deal value$20M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- XOMA Royalty Corp (XOMA)
- Target
- Pulmokine
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Dec 2, 2024
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations